| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | Feb 13, 2024 | Option Exercise | $6.53 | 1,735 | 11,330 | 24,951 | Feb 15, 2024, 05:07 PM | |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | Aug 30, 2023 | Option Exercise | $2.93 | 661 | 1,937 | 26,686 | Aug 31, 2023, 04:12 PM | |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | Jan 30, 2023 | Option Exercise | $7.78 | 1,301 | 10,122 | 5,097 | Feb 01, 2023, 04:09 PM | |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | May 26, 2022 | Option Exercise | $7.01 | 1,102 | 7,725 | 2,648 | Jun 14, 2022, 04:45 PM | |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | Sep 10, 2021 | Option Exercise | $27.49 | 25,000 | 687,250 | 12,500 | Sep 14, 2021, 04:08 PM | |
| CCCC | C4 Therapeutics, Inc. | Siegel Jolie | Chief Legal Officer | Jul 29, 2021 | Option Exercise | $24.99 | 25,000 | 624,750 | 12,500 | Aug 02, 2021, 06:49 PM | |
| NTGN | Neon Therapeutics, Inc. | Siegel Jolie | VP, General Counsel | Feb 29, 2020 | Option Exercise | $1.50 | 2,845 | 4,268 | 161,821 | Mar 02, 2020, 06:39 PM | |
| NTGN | Neon Therapeutics, Inc. | Siegel Jolie | VP, General Counsel | Feb 25, 2020 | Option Exercise | $1.51 | 5,334 | 8,054 | 164,666 | Feb 27, 2020, 06:21 PM |
Menu